Dr Yudhishter Mohan Bhatnagar, MD | |
240 Allegheny Blvd, Suite C, Brookville, PA 15825-2323 | |
(814) 849-4611 | |
(814) 849-8746 |
Full Name | Dr Yudhishter Mohan Bhatnagar |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology - Reproductive Endocrinology |
Location | 240 Allegheny Blvd, Brookville, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609864719 | NPI | - | NPPES |
0005873780003 | Medicaid | PA | |
000066370 | Other | PA | HIGHMARK BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | MD018998E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Yudhishter Mohan Bhatnagar, MD Po Box 447, Du Bois, PA 15801-0447 Ph: (814) 849-4611 | Dr Yudhishter Mohan Bhatnagar, MD 240 Allegheny Blvd, Suite C, Brookville, PA 15825-2323 Ph: (814) 849-4611 |
News Archive
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 435-440(6); DOI: https://doi.org/10.15212/CVIA.2017.0070 Tracy Ashby, DO and Mariam Louis, MD, MSc, FCCP from the University of Florida, Department of Medicine, Jacksonville, FL, USA consider circadian misalignment and cardiovascular risk.
Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
The European R&D project BrainAble, led by Barcelona Digital, has just successfully ended by developing a prototype that allows patients with severe functional disability to be more active and independent.
Fragile bones are usually an old person's affliction, but sometimes children are born with them. Now, a team of researchers led by UConn professor Ernesto Canalis has shown in mice that a specific gene can cause the disease, called Hajdu-Cheney syndrome. Overabundant bone-absorbing cells may be causing the disorder's characteristic bone loss, and the researchers hope to find a potential treatment.
› Verified 1 days ago